Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 9 (6), e1001228

Clinical Trials Have Gone Global: Is This a Good Thing?

Affiliations
Review

Clinical Trials Have Gone Global: Is This a Good Thing?

Trudie Lang et al. PLoS Med.

Abstract

As part of a cluster of articles leading up to the 2012 World Health Report and critically reflecting on the theme of “no health without research,” Trudie Lang and Sisira Siribaddana discuss the value and challenges of doing clinical trials in developing countries.

Conflict of interest statement

SS has been funded by the Wellcome Trust UK and had several travel grants from Servier (before 1999), Novo Nordisk (before 1999), and Elly Lilly (before 1999). SS is also ethics review committee chairman of the Faculty of Medicine and Allied Sciences Rajarata University of Sri Lanka. TAL has declared that no competing interests exist.

Similar articles

See all similar articles

Cited by 37 PubMed Central articles

See all "Cited by" articles

References

    1. Laine C, Horton R, DeAngelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration — looking back and moving ahead. N Engl J Med. 2009;356:2734–2736. - PubMed
    1. Morgan S, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy. 2011;100:4–17. - PubMed
    1. Yusuf S, Bosch J, Devereaux P. Sensible guidelines for the conduct of large randomized trials. Clin Trials. 2008;5:38–39. - PubMed
    1. Lang T, Cheah PY, White NJ. Clinical research: time for sensible global guidelines. Lancet. 2011;377:1553–1555. - PubMed
    1. Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, et al. Ethical and scientific implications of the globalization of clinical research. N Engl J Med. 2009;360:816–823. - PubMed
Feedback